These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12739838)

  • 1. P-ANCA positive renal vasculitis in association with renal cell carcinoma and prolonged hydralazine therapy.
    Norris JH; Leeds J; Jeffrey RF
    Ren Fail; 2003 Mar; 25(2):311-4. PubMed ID: 12739838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
    Kumar B; Strouse J; Swee M; Lenert P; Suneja M
    Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
    Dobre M; Wish J; Negrea L
    Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.
    Tu W; Fayman B; Ward SC; Mamoon Y; Bandagi SS
    Am J Case Rep; 2021 May; 22():e931263. PubMed ID: 33993184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.
    Chen YX; Yu HJ; Ni LY; Zhang W; Xu YW; Ren H; Chen XN; Wang XL; Li X; Pan XX; Wang WM; Chen N
    J Rheumatol; 2007 Dec; 34(12):2451-6. PubMed ID: 17985400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection.
    Rasla S; El Meligy A; Cucu DF
    R I Med J (2013); 2016 Nov; 99(11):41-43. PubMed ID: 27801920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pauci-immune renal vasculitis: natural history, prognostic factors, and impact of therapy.
    Cohen BA; Clark WF
    Am J Kidney Dis; 2000 Nov; 36(5):914-24. PubMed ID: 11054347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydralazine associated pauci-immune glomerulonephritis.
    Suneja M; Baiswar S; Vogelgesang SA
    J Clin Rheumatol; 2014 Mar; 20(2):99-102. PubMed ID: 24561415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydralazine-associated cutaneous casculitis presenting with aerodigestive tract involvement.
    Levin LE; Magro C; Horowitz J; Harp J
    Cutis; 2017 May; 99(5):E25-E29. PubMed ID: 28632810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-induced MPO-ANCA Renal-Limited Vasculitis Masquerading as Lupus Nephritis.
    Baloch NU; Ibeabuchi AN
    J Coll Physicians Surg Pak; 2018 Nov; 28(11):896-897. PubMed ID: 30369391
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Gaskin G; Pusey CD
    Ther Apher; 2001 Jun; 5(3):176-81. PubMed ID: 11467753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis.
    Zuckerman R; Patel M; Costanzo EJ; Dounis H; Haj RA; Seyedali S; Asif A
    J Bras Nefrol; 2018; 40(2):193-197. PubMed ID: 29738027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
    Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.
    Short AK; Lockwood CM
    QJM; 1995 Nov; 88(11):775-83. PubMed ID: 8542262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.
    Stangou M; Asimaki A; Bamichas G; Christidou F; Zoumbaridis N; Natse T; Galanis N; Christaki P; Patakas D; Sombolos K
    J Nephrol; 2005; 18(1):35-44. PubMed ID: 15772921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis After 10 Years of Hydralazine Use.
    Russe-Russe JR; Pellegrini JR; Alvarez-Betancourt A; Munshi RF; Anand P
    Cureus; 2021 Oct; 13(10):e18974. PubMed ID: 34820229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
    Marina VP; Malhotra D; Kaw D
    Int Urol Nephrol; 2012 Dec; 44(6):1907-9. PubMed ID: 21590349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and pathological characterization of antineutrophil cytoplasmic antibody associated small vasculitis in children].
    Zhou JH; Tang JH; Shi H; Liu TL; Qiu LR; Chen Y
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):408-11. PubMed ID: 15265421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis.
    Gallagher JL; Sinha S; Reeve R; Kalra PA
    Postgrad Med J; 2008 Apr; 84(990):220-2. PubMed ID: 18424581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
    Santoriello D; Bomback AS; Kudose S; Batal I; Stokes MB; Canetta PA; Radhakrishnan J; Appel GB; D'Agati VD; Markowitz GS
    Kidney Int; 2021 Aug; 100(2):440-446. PubMed ID: 33857570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.